ID
12738
Beskrivning
Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT02185781
Länk
https://clinicaltrials.gov/show/NCT02185781
Nyckelord
Versioner (1)
- 2015-12-17 2015-12-17 -
Uppladdad den
17 december 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Acute Lymphoblastic Leukemia NCT02185781
Eligibility Acute Lymphoblastic Leukemia NCT02185781
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
concomitant therapy
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1707479
Beskrivning
contraindication
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1301624
Beskrivning
infection
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0009450
Beskrivning
autoimmune symptoms
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0004364
Beskrivning
pregnant or breastfeeding
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Beskrivning
Study subject participation status
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2348568
Beskrivning
any physical or psychological impediment in a patient that could lead the investigator to suspect his/her poor compliance to the protocol.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1321605
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT02185781
- StudyEvent: Eligibility
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0018724 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])